Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The accumulated evidence over recent decades regarding the efficacy of new pharmacological treatments for obesity has positioned the glucagon-like peptide-1 (GLP-1) analogue as a key componentwhether as monoagonists, unimolecular multiagonists, or in combination therapies targeting multiple receptors.1 These drugs have made it possible to achieve previously unthinkable goals in terms of weight reduction and control of various obesity-related comorbidities (Fig
, -, -
Final Results: While an immediate difference in body contour can be discerned after the surgery, the definitive and polished results manifest once all the swelling recedes and the body adapts to its new shape
doi:10.1016/S2213-8587(19)30068-3 11
US$ 22.92
US$ 29.09
US$ 25.54
